Broadway posters hang outside the Richard Rodgers Theatre during Covid-19 lockdown in New York on May 13, 2020. Many Broadway productions are scrambling to resume ticket sales to welcome theater-goers this fall after city and state leaders have green-lit a reopening of the Great White Way at full capacity. Gov. Andrew Cuomo said Broadway theaters can reopen Sept. 14 and will be allowed to decide their own entry requirements. (Photo by Evan Agostini/Invision/AP, File)
By Mark Kennedy
Many Broadway productions are scrambling to resume ticket sales in the coming days to welcome theater-goers this fall after city and state leaders have green-lit a reopening of the Great White Way at full capacity by mid-September.
“We remain cautiously optimistic about Broadway’s ability to resume performances this fall and are happy that fans can start buying tickets again,” Charlotte St. Martin, president of the Broadway League, said in a statement Wednesday.
New York Gov. Andrew Cuomo said Broadway theaters can reopen Sept. 14 and will be allowed to decide their own entry requirements, like whether people must prove they've been vaccinated to attend a show. Selling tickets will allow theaters to gauge interest before stages open, said Robert Mujica, Cuomo’s budget director.
"Phantom of the Opera,” Broadway's longest-running show, announced Wednesday it would resume performances on Oct. 22, with tickets going on sale Friday. More shows are expected to circle return dates in the coming weeks.
Actors’ Equity Association, the national labor union representing more than 51,000 actors and stage managers in live theater, said the news meant the theater community is “one step closer to the safe reopening" of Broadway.
“We look forward to continuing our conversations with the Broadway League about a safe reopening and know that soon the time will come when members can go back to doing what they do best, creating world-class theater,” said Mary McColl, executive director of Actors’ Equity.
The Broadway that reopens will look different. In May, the big budget Disney musical “Frozen” decided not to reopen when Broadway theaters restart, marking the first time an established show had been felled by the coronavirus pandemic. Producers of “Mean Girls” also decided not to restart.
But there will be new shows, including Antoinette Chinonye Nwandu’s “Pass Over” that is slated to reopen the August Wilson Theatre, the same venue “Mean Girls” has vacated. And a Shubert theater has been promised for playwright Keenan Scott II’s play “Thoughts of a Colored Man.”
The lifting of all capacity restrictions has long been considered by the industry as crucial to any reopening plan since Broadway economics demand full venue capacity. Some off-Broadway shows have already reopened with limited capacity.
All city theaters abruptly closed on March 12, 2020, knocking out all shows, including 16 that were still scheduled to open.
Some scheduled spring 2020 shows — like a musical about Michael Jackson and a revival of Neil Simon’s “Plaza Suite” starring Matthew Broderick and Sarah Jessica Parker — pushed their productions to 2021. But others abandoned their plans, including “Hangmen” and a revival of Edward Albee’s “Who’s Afraid of Virginia Woolf?”
TC BioPharm, a biopharmaceutical company focused on developing cell therapy products targeting, went public on the Nasdaq in January. CEO Bryan Kobel joined Cheddar to talk about the company's IPO launch, its cancer-fighting therapeutics tech, and its potential for using its research to treat COVID-19. "The opportunity here for us is to really get safety data and covid and expand into other areas," Kobel said. "So from COVID, where we hope to treat patients, hopefully maybe the elderly population, populations that that really can't handle the antivirals because they're too hard in the system, well then we'll expand out into maybe severe influenza Ebola, other viral and viral infections where we think we can be helpful."
The gaming industry has been under the spotlight so far this year following some big mergers and acquisitions. This week featured earnings of three major gaming companies, but also Meta and for the latter, things are not doing too hot. Joining Cheddar News to break it all down was Kenny Rosenblatt, President and Co-Founder of Arkadium.
Following the surprising big beat on estimates for the January jobs report, William M. Rodgers III, vice president and director of the Institute for Economic Equity at the Federal Reserve Bank of St. Louis, joined Cheddar News to break down the data. “We ended 2021 with a strong crescendo to a recovery that had taken hold, and we started 2022 in good fashion." He also discussed the dueling pressures of wage growth and inflation.
While it was a volatile week in tech as Meta experienced the biggest one-day drop in the history of the U.S. stock market, industry giant Amazon reported 40 percent growth — largely on the strength of the cloud. Dan Ives, managing director of equity research at Wedbush Securities, joined Cheddar News to break down how the e-commerce company stock managed to pop despite headwinds against its core retail business. "It's all about cloud because of sum of the parts, you could argue, amazon could be $3,500/$4,000 stock just based on cloud," he said. Ives also addressed the apparent the differing impact of Apple iOS changes on Facebook and Snapchat.
Following Ford's earnings miss, the stock price dropped despite a bullish outlook from the auto giant. Karl Brauer, an executive analyst with ISeeCars.com, joined Cheddar to break down why investors may not be sold on the carmaker because of the ongoing factor of supply constraints. "The product is not an issue. There's really good product coming from them, including the electric vehicle side, and the demand is not an issue. There's plenty of demand, but nobody really has a solid grasp on when we're going to get past the supply chain issue," said Brauer.
